Mon, April 16, 2012
[ Mon, Apr 16th 2012 ]: Market Wire
BARDA Exercises $9.1 Million in Contract Options With Aeolus
[ Mon, Apr 16th 2012 ]: Market Wire
Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer
[ Mon, Apr 16th 2012 ]: Market Wire
La Jolla Pharmaceutical Company Announces Development Programs for Lead Product, GCS-100
[ Mon, Apr 16th 2012 ]: Market Wire
Troublesome March for Stem Cell Companies
[ Mon, Apr 16th 2012 ]: Market Wire
Ruling in Texas Could Provide New Opportunities for Stem Cell Companies
[ Mon, Apr 16th 2012 ]: Market Wire
Equity Research on Endo Pharmaceuticals Holdings .. Inc. - Drug Manufacturers Acquiring and Expanding
[ Mon, Apr 16th 2012 ]: Market Wire
Cynapsus Provides Update and 2012 Outlook
[ Mon, Apr 16th 2012 ]: Market Wire
Trimel Pharmaceuticals Corporation Provides CompleoTRT(TM) Phase III Recruitment Update
[ Mon, Apr 16th 2012 ]: Market Wire
Merck and Endocyte Enter Exclusive Worldwide Agre .. alize Phase III Cancer Candidate Vintafolide (EC1
[ Mon, Apr 16th 2012 ]: Market Wire
Reintegration Awards Recognize Service to People With Mental Illness
[ Mon, Apr 16th 2012 ]: Market Wire
Vanda Pharmaceuticals Acquires Rights to NK-1 Receptor Antagonist from Eli Lilly and Company
[ Mon, Apr 16th 2012 ]: Market Wire
Percutaneous Tibial Nerve Stimulation (PTNS) for .. ffirmation of Efficacy and Safety in Agency for H
[ Mon, Apr 16th 2012 ]: Market Wire
Medtronic Endurant AAA Stent Graft Shows Durable Performance at Two Years in U.S. Study
[ Mon, Apr 16th 2012 ]: Market Wire
Express Scripts Launches ScreenRx(SM), Industry's .. ly Detection and Tailored Interventions to Addres
[ Mon, Apr 16th 2012 ]: Market Wire
Illumina to Announce First Quarter 2012 Results on Monday, April 23, 2012
Sun, April 15, 2012
[ Sun, Apr 15th 2012 ]: Market Wire
DaVita Announces CFO Transition
[ Sun, Apr 15th 2012 ]: Market Wire
Biodel Reports Positive Top-Line Results from Stu .. erimental Ultra-Rapid-Acting Insulin Formulations
Sat, April 14, 2012
[ Sat, Apr 14th 2012 ]: Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of eResearchTechnology, Inc.
Fri, April 13, 2012
[ Fri, Apr 13th 2012 ]: Market Wire
Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study
[ Fri, Apr 13th 2012 ]: Market Wire
Immunovaccine Inc. Named "Best Early-Stage Vaccin .. the 5th Vaccine Industry Excellence (ViE) Awards
[ Fri, Apr 13th 2012 ]: Market Wire
Lakeland Industries Announces Significant Developments in Its Global Transformation
[ Fri, Apr 13th 2012 ]: Market Wire
ACADIA Pharmaceuticals to Present at the 19th Ann .. the Biotech Industry Conference on April 20, 2012
[ Fri, Apr 13th 2012 ]: Market Wire
BOTOX Cosmetic (onabotulinumtoxinA) Celebrates 10 .. ary of U.S. Food and Drug Administration Approval
[ Fri, Apr 13th 2012 ]: Market Wire
NxStage to Report First Quarter Fiscal 2012 Financial Results
[ Fri, Apr 13th 2012 ]: Market Wire
Unilife Corporation to Announce Financial Results .. al 2012 Third Quarter on Thursday, April 26, 2012
[ Fri, Apr 13th 2012 ]: Market Wire
Infinity Pharmaceuticals to Present at Two Upcoming Conferences
[ Fri, Apr 13th 2012 ]: Market Wire
Affymax and Takeda Announce Centers for Medicare .. igned a Q-Code for OMONTYS (Peginesatide) Injecti
[ Fri, Apr 13th 2012 ]: Market Wire
Tornier Announces 2012 Facility Consolidations
[ Fri, Apr 13th 2012 ]: Market Wire
Oncothyreon to Present at Future Leaders in the Biotech Industry Conference
[ Fri, Apr 13th 2012 ]: Market Wire
Threshold Pharmaceuticals Announces Presentation .. d Webcast at BioCentury Future Leaders Conference
[ Fri, Apr 13th 2012 ]: Market Wire
Mylan Launches First Generic Version of Lescol Capsules
[ Fri, Apr 13th 2012 ]: Market Wire
Theratechnologies Announces Financial Results for First Quarter of 2012
[ Fri, Apr 13th 2012 ]: Market Wire
Delcath Announces First Patient Treatment Using Second Generation Hemofiltration Cartridge
Thu, April 12, 2012
[ Thu, Apr 12th 2012 ]: Market Wire
Healthnostics Stockholders to Receive Multiple Stock Issuances
[ Thu, Apr 12th 2012 ]: Market Wire
Masimo Pronto-7a" Receives China and South Korea Regulatory Clearances
[ Thu, Apr 12th 2012 ]: Market Wire
Advances in Stereotactic Radiosurgery are Enablin .. fective, Non-Invasive Treatment for Spinal Tumors
[ Thu, Apr 12th 2012 ]: Market Wire
Shire Adds new Technology Platform and Phase 2 Pr .. t Candidate to its Regenerative Medicine Business
[ Thu, Apr 12th 2012 ]: Market Wire
Rosetta Genomics to Raise $1.38 Million in Registered Direct Offering
[ Thu, Apr 12th 2012 ]: Market Wire
CryoLife Announces Release Date and Teleconferenc .. Details for 2012 First Quarter Financial Results
[ Thu, Apr 12th 2012 ]: Market Wire
Northwest Bio Partners With King's College Hospit .. and King's College London for Programs in Europe
[ Thu, Apr 12th 2012 ]: Market Wire
CytRx Announces Issuance of Key U.S. Patent Covering INNO-206 Linker Technology
[ Thu, Apr 12th 2012 ]: Market Wire
Research on Mylan Inc. and Watson Pharmaceuticals Inc. - Generic Drug Makers Take to the Courts
[ Thu, Apr 12th 2012 ]: Market Wire
Valeant Pharmaceuticals to Acquire Pedinol
[ Thu, Apr 12th 2012 ]: Market Wire
Varian Medical Systems Holds Workshop in Advanced Radiotherapy Techniques for African Clinicians
[ Thu, Apr 12th 2012 ]: Market Wire
AcelRx Announces Initiation of Second Phase 3 Cli .. ufentanil NanoTab PCA System, for the Treatment o
[ Thu, Apr 12th 2012 ]: Market Wire
Nuvo Research Provides Pennsaid Update
[ Thu, Apr 12th 2012 ]: Market Wire
PDL BioPharma to Hold Annual Meeting of Stockholders on June 5, 2012
[ Thu, Apr 12th 2012 ]: Market Wire
Perceptive Informatics Enables Greater Trial Supp .. iciency With New Site Inventory Management Module

Oncothyreon to Present at Future Leaders in the Biotech Industry Conference

Oncothyreon to Present at Future Leaders in the Biotech Industry Conference

Oncothyreon to Present at Future Leaders in the Biotech Industry Conference

[ ]

SEATTLE, April 13, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will be presenting at the 19th Annual Future Leaders in the Biotech Industry Conference, presented by BioCentury and Thomson Reuters, in New York on Friday, April 20, 2012 at 9:30 a.m. Eastern.

A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website [ www.oncothyreon.com ] under the "News & Events" section.

About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit [ www.oncothyreon.com ].

SOURCE Oncothyreon Inc.

[ Back to top ]